BIOCELLIC+
LIVE

Serial Number

79204909

Owner

JeNaCell GmbH

Filing Date

Jan 28, 2016

Add to watchlist:

No watchlists yet
View on USPTO

BIOCELLIC+ Trademark

Serial Number: 79204909 • Registration: 5557605

BIOCELLIC+ is a trademark filed by JeNaCell GmbH on January 28, 2016. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

JeNaCell GmbH (4 trademarks)

Göschwitzer Str. 22

Entity Type: 99

Trademark Details

Filing Date

January 28, 2016

Registration Date

September 11, 2018

Published for Opposition

June 26, 2018

Cancellation Date

March 28, 2025

Goods & Services

Cellulose precursors and cellulose intermediates for cosmetic, pharmaceutical, medical and veterinary-medical end products; cellulose products for use in the manufacture of wound dressings; cellulose made by bacteria; cellulose for industrial purposes; cellulose gel for use in manufacturing; nanocellulose for use in manufacturing; unprocessed cellulose fleece, cellulose foil, cellulose films and cellulose fibres, all for use in manufacturing goods in the cosmetic and medical industries; cellulose fibres suspensions and cellulose gels of nanocellulose; cellulose fibres suspensions and cellulose gels of cellulose and water; unprocessed cellulose fleece, cellulose foil, cellulose films and cellulose fibres for use in food and beverages; cellulose fibres suspensions and cellulose gels for use in food and beverages; Thickening agents being biochemical products for industrial use; cellulose and nanocellulose products as precursors for veterinary, and cosmetic products, particularly for wound dressings; cellulose ingredients for use in manufacturing goods in the cosmetic and medical industries; cellulose and nanocellulose products as precursors for pharmaceutical products; [ cellulose-based ingredients for manufacturing goods in the cosmetics industry and the medical device industry; ] cellulose-based ingredients as support material, thickening and binding agents for the manufacture of cosmetics and medical products, particularly wound dressings and skin care preparations; cellulose for the food industry; cellulose derivatives for use in manufacturing; diagnostic preparations and substances for scientific purposes; diagnostic testing materials for scientific use; * none of the above-mentioned goods being products to be taken orally; none of the above-mentioned goods being products containing collagen *

Pharmaceutical preparations for skin care; pantyliners; sanitary pads; medicated preparations for the treatment of burns with the exception of ready-to-use wound dressings; diagnostic preparations for pharmaceutical, medical and veterinary purposes; * none of the above-mentioned goods are sticking plasters or plasters for medical use and none of the above-mentioned goods are ready-to-use surgical dressings; insofar as the above-mentioned goods relate to non-pharmaceutical products, the latter are not provided for oral medication; insofar as the above-mentioned goods relate to pharmaceutical products to be taken orally, the latter are free from collagen, chondroitin sulfate and/or hyaluronic acid; none of the above-mentioned goods are nutritional supplements containing collagen, chondroitin sulfate and/or hyaluronic acid; none of the above-mentioned goods are products containing collagen *

Cosmetics and cosmetic preparations; cellulose fleece, cellulose foils, cellulose films, cellulose fibres, cellulose fibre suspensions and cellulose gels impregnated with cosmetic active ingredients, particularly skin care preparations; beauty masks; skin masks; facial masks; body masks, unmedicated skin care preparations; * none of the above-mentioned goods being products containing collagen *

Filing History

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 28, 2025 INTR
CANCELLED SECTION 71
Mar 28, 2025 C71T
NEW REPRESENTATIVE AT IB RECEIVED
Feb 18, 2023 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Aug 12, 2022 ADCH
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Oct 21, 2019 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 4, 2019 INPR
FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 15, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 24, 2019 FICS
FINAL DISPOSITION PROCESSED
Jan 24, 2019 FIMP
LIMITATION FROM THE IB EXAMINED AND ENTERED
Jan 24, 2019 LIME
CORRECTION UNDER SECTION 7 - PROCESSED
Jan 23, 2019 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 7, 2019 APRE
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Dec 11, 2018 FICR
LIMITATION OF GOODS RECEIVED FROM IB
Nov 2, 2018 LIMG
REGISTERED-PRINCIPAL REGISTER
Sep 11, 2018 R.PR
PUBLISHED FOR OPPOSITION
Jun 26, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Jun 23, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 6, 2018 OPNS
NOTICE OF PUBLICATION
Jun 6, 2018 NPUB
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jun 6, 2018 OP2R
WITHDRAWN FROM PUB - OG REVIEW QUERY
Apr 10, 2018 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 22, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 2, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 1, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 1, 2018 TROA
NON-FINAL ACTION MAILED
Nov 21, 2017 CNRT
NON-FINAL ACTION WRITTEN
Nov 21, 2017 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 30, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 30, 2017 CRFA
ASSIGNED TO LIE
Oct 30, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 18, 2017 TROA
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Oct 18, 2017 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Aug 25, 2017 LIMG
REFUSAL PROCESSED BY IB
May 5, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 19, 2017 RFCS
REFUSAL PROCESSED BY MPU
Apr 19, 2017 RFRR
APPLICATION FILING RECEIPT MAILED
Apr 18, 2017 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 16, 2017 RFCR
NON-FINAL ACTION WRITTEN
Apr 15, 2017 CNRT
ASSIGNED TO EXAMINER
Apr 14, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 14, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 13, 2017 REPR